Central Retinal Vein Occlusion

What is central retinal vein occlusion?

Central retinal vein occlusion, often shortened to CRVO, is an eye condition in which the main vein that drains blood away from the retina becomes blocked. The retina is the thin layer of light-sensitive tissue at the back of the eye that captures images and sends them to the brain. Like every tissue in the body, the retina needs a constant supply of blood. Blood arrives through the central retinal artery and leaves through the central retinal vein. When that vein is blocked, blood cannot drain properly. Pressure builds up in the smaller vessels of the retina, fluid and blood leak into the surrounding tissue, and the retina can become swollen and starved of oxygen. This can blur or dim the vision, sometimes suddenly and sometimes over hours or days.

Central retinal vein occlusion usually affects one eye at a time. It is more common in people over the age of 50, and the risk rises with age, although younger adults can develop it, particularly if they have blood-clotting disorders, inflammation inside the eye, or certain other health conditions. CRVO is closely linked to conditions that affect blood vessels throughout the body, such as high blood pressure, diabetes, and glaucoma (a group of eye diseases in which pressure inside the eye damages the optic nerve).

Doctors generally describe two broad forms of the condition. In the non-ischemic form, blood flow is reduced but the retina still receives a reasonable amount of oxygen; vision loss is often milder. In the ischemic form, large areas of the retina are severely deprived of oxygen; vision loss tends to be more significant, and the risk of complications is higher. A non-ischemic occlusion can sometimes progress to the ischemic form over time, which is one reason ongoing follow-up with an eye specialist is important.

Symptoms of central retinal vein occlusion

Central retinal vein occlusion symptoms typically appear in one eye only and are painless in most cases. Some people notice a sudden change in vision when they wake up in the morning; others describe a gradual worsening over several hours or days. Common symptoms include:

• Blurred or hazy vision in one eye, ranging from mild to severe.
• Sudden, painless loss of vision in part or all of the visual field of one eye.
• Dark spots or floaters — small shapes that drift across the vision, which can occur when blood leaks into the clear gel inside the eye.
• Distorted vision, where straight lines may look wavy, often caused by swelling in the central part of the retina.
• A dim or gray appearance to vision in the affected eye.

Symptoms often differ depending on the type of occlusion. In the non-ischemic form, vision may be only mildly blurred, and some people notice the problem only when they happen to cover the healthy eye. In the ischemic form, vision loss is usually more sudden and more severe, and it may affect most of the visual field in that eye.

Pain is not typical in the early stages. However, weeks or months after an ischemic occlusion, some people develop a serious complication called neovascular glaucoma. In this condition, abnormal new blood vessels grow in the eye and raise the pressure inside it, which can cause eye pain, redness, headache, and further vision loss. This complication needs urgent treatment, so any new pain or redness in an eye that has had a vein occlusion should be reported to a doctor promptly.

Causes and risk factors

Central retinal vein occlusion causes are usually related to the health of the blood vessels and the blood itself. In most cases, the vein becomes blocked by a blood clot (a thrombus) that forms where the central retinal vein passes through a narrow channel at the back of the eye, close to the central retinal artery. If the nearby artery has become stiff and thickened — a common result of aging, high blood pressure, or atherosclerosis (a buildup of fatty deposits inside artery walls) — it can compress the vein and slow the blood flow, making a clot more likely to form.

Well-recognized risk factors include:

• Age over 50, with risk continuing to rise in later decades.
• High blood pressure (hypertension), one of the most common associated conditions.
• Diabetes, which damages small blood vessels throughout the body, including in the retina.
• High cholesterol and atherosclerosis, which harden and narrow the arteries.
• Glaucoma, especially open-angle glaucoma, which is more common in people who develop CRVO.
• Smoking, which harms blood vessels and increases clotting tendency.
• Obesity and lack of physical activity.
• Blood-clotting or blood-thickening disorders, such as inherited clotting conditions or diseases that increase the number of blood cells; these are particularly relevant in younger patients.
• Inflammatory conditions affecting blood vessels or the inside of the eye.
• Certain medications, such as some hormonal treatments, may be considered by your doctor as possible contributing factors in selected cases.

In many people, more than one of these factors is present at the same time. Because CRVO can be a sign of broader cardiovascular disease, doctors often use the diagnosis as an opportunity to check blood pressure, blood sugar, and cholesterol, and to review overall vascular health.

Diagnosis

Central retinal vein occlusion diagnosis begins with a detailed eye examination by an ophthalmologist — a medical doctor who specializes in eye diseases. After asking about your symptoms and medical history, the doctor will usually place dilating drops in the eye to widen the pupil, which allows a clear view of the retina at the back of the eye. In CRVO, the retina typically shows a characteristic pattern: widespread scattered hemorrhages (small areas of bleeding), swollen and twisted veins, and often swelling of the optic disc, the point where the optic nerve enters the eye.

Several tests help confirm the diagnosis and guide treatment:

• Visual acuity testing measures how well you can read letters on a chart and helps establish the severity of vision loss.
• Optical coherence tomography (OCT) is a painless scan that uses light waves to create detailed cross-sectional images of the retina. It shows whether the macula — the central part of the retina responsible for sharp, detailed vision — is swollen. This swelling, called macular edema, is the most common cause of vision loss in CRVO, and OCT is also used to monitor how well treatment is working.
• Fluorescein angiography involves injecting a harmless dye into a vein in the arm and photographing the retina as the dye travels through its blood vessels. It shows where blood flow is blocked, where vessels are leaking, and how much of the retina is ischemic (deprived of oxygen). This helps distinguish the non-ischemic from the ischemic form.
• Eye pressure measurement (tonometry) checks for glaucoma and monitors for the raised pressure that can develop as a complication.
• Blood tests may be arranged, especially in younger patients or when no obvious risk factor is found, to look for diabetes, high cholesterol, clotting disorders, or inflammatory conditions.

Because CRVO often reflects vascular disease elsewhere in the body, your eye doctor may also recommend a general medical review with your family physician or an internal medicine specialist.

Treatment options

There is currently no treatment that can reliably remove the blockage in the central retinal vein itself. Instead, central retinal vein occlusion treatment focuses on managing the consequences of the blockage — mainly macular edema and abnormal new blood vessel growth — and on protecting the vision that remains. Conditions of the retina, including CRVO, are managed by retina specialists within an ophthalmology department.

Observation and monitoring

In mild, non-ischemic cases with good vision and little or no macular swelling, your doctor may recommend careful observation rather than immediate treatment. Some mild occlusions improve on their own as the eye develops alternative drainage channels. Regular follow-up visits with repeated OCT scans are important, because the condition can worsen or progress to the ischemic form over time.

Anti-VEGF injections

The most widely used treatment for macular edema caused by CRVO is injection of anti-VEGF medication into the eye. VEGF (vascular endothelial growth factor) is a natural protein that the oxygen-starved retina produces in excess; it makes blood vessels leaky and encourages the growth of abnormal new vessels. Anti-VEGF drugs block this protein, which in many cases reduces retinal swelling and improves or stabilizes vision. The injections are given in a clinic after numbing drops are applied, and most people find them far less uncomfortable than they expect. Treatment usually begins with a series of monthly injections, and the interval between injections may then be extended based on how the retina responds. Many patients need repeated injections over months or years.

Steroid injections and implants

Corticosteroid medication, delivered as an injection or a slow-release implant placed inside the eye, is another option for macular edema, particularly when anti-VEGF injections are not suitable or have not worked well. Steroids reduce inflammation and vessel leakage, but they can raise eye pressure and speed up cataract formation (clouding of the eye’s natural lens), so your doctor will weigh the benefits and risks in your individual case.

Laser treatment

If the ischemic form of CRVO leads to abnormal new blood vessels on the iris or retina, a laser treatment called panretinal photocoagulation may be recommended. The laser is applied to the oxygen-starved outer parts of the retina to reduce the drive for new vessel growth and lower the risk of neovascular glaucoma and bleeding inside the eye. This treatment aims to prevent complications rather than to restore vision that has already been lost.

Surgery

Surgery is not a routine treatment for CRVO itself, but it may become necessary for certain complications. If blood leaks into the vitreous — the clear gel that fills the eye — and does not clear on its own, a procedure called vitrectomy may be performed to remove the blood-filled gel and restore a clear path for light. Vitrectomy may also be considered in some cases involving scar tissue or retinal detachment. If neovascular glaucoma develops and cannot be controlled with medication and laser, glaucoma procedures may be needed to lower the eye pressure.

Treating underlying conditions

Alongside eye treatments, managing the underlying risk factors is essential. Your doctors may adjust treatment for high blood pressure, diabetes, or high cholesterol, and will usually advise stopping smoking. Good control of these conditions supports the health of the other eye and the rest of the circulatory system, although it cannot undo the occlusion that has already occurred.

Living with central retinal vein occlusion and outlook

The outlook after central retinal vein occlusion varies widely and depends largely on the type of occlusion, how severe the initial vision loss was, and how well macular edema responds to treatment. People with the non-ischemic form and good starting vision often maintain useful sight in the affected eye, especially with timely treatment. The ischemic form carries a more guarded outlook, and severe vision loss may not fully recover even with treatment. It is honest to say that some vision loss can be permanent, while in many cases treatment meaningfully improves or stabilizes sight; no doctor can guarantee a particular outcome.

Living with CRVO usually means committing to regular follow-up appointments, sometimes for years. Repeated OCT scans and, when needed, repeated injections are a normal part of long-term care. Many people adapt well, particularly when the other eye is healthy. Practical steps that can help include using good lighting for reading, considering low-vision aids if central vision is affected, and monitoring the vision in each eye separately at home — for example, by briefly covering one eye each day — so that any new change is noticed early. Because the fellow eye carries a somewhat higher risk of a similar event, protecting overall vascular health through blood pressure control, diabetes management, a balanced diet, regular activity, and not smoking is an important part of living with this condition.

Frequently asked questions

What is central retinal vein occlusion in simple terms?

It is a blockage, usually by a blood clot, of the main vein that drains blood from the retina at the back of the eye. Because blood cannot leave properly, it backs up, leaks into the retina, and causes swelling and bleeding that blur or reduce vision, typically in one eye.

Can central retinal vein occlusion heal on its own?

Mild, non-ischemic occlusions sometimes improve without treatment as the eye develops alternative drainage routes. However, many cases involve macular swelling that benefits from treatment, and some progress to a more severe form. Because it is not possible to predict which cases will improve on their own, regular monitoring by an ophthalmologist is generally recommended even when no treatment is given at first.

How serious is central retinal vein occlusion?

It is a potentially serious condition. Some people are left with only mild blurring, while others lose most of the vision in the affected eye, particularly with the ischemic form. It can also lead to complications such as neovascular glaucoma if not monitored. In addition, CRVO can be a warning sign of cardiovascular risk factors that deserve attention, such as high blood pressure or diabetes.

What are the first symptoms of central retinal vein occlusion?

The most common first symptom is painless blurring or loss of vision in one eye, which may be sudden or develop over hours to days. Some people notice floaters, a dim or gray quality to their vision, or distortion of straight lines. Because it is painless, mild cases can go unnoticed until the healthy eye is covered.

Can vision recover after central retinal vein occlusion?

Vision can improve in many cases, especially when macular swelling responds to anti-VEGF or steroid treatment and when the occlusion is non-ischemic. Recovery is often partial rather than complete, and severe ischemic occlusions may leave lasting vision loss. Early diagnosis and consistent follow-up give the best chance of preserving sight, but outcomes vary from person to person.

How is central retinal vein occlusion different from a stroke?

A stroke affects blood flow to the brain, while CRVO affects blood drainage from the retina in the eye. They are different events, but they share many risk factors, such as high blood pressure, diabetes, and atherosclerosis. For this reason, doctors often recommend a general vascular health check after a retinal vein occlusion is diagnosed.

Will I need injections in my eye forever?

Not necessarily, although many patients need repeated injections over an extended period. Treatment usually starts with a series of monthly injections, and the interval is then adjusted according to how the retina responds on OCT scans. In some people the swelling settles and injections can be paused or stopped; in others, longer-term treatment is needed to keep the swelling controlled. Your retina specialist will tailor the schedule to your eye’s response.

When to see a doctor

Any sudden change in vision should be assessed by an eye doctor as soon as possible, because early diagnosis can influence treatment options and outcomes. Seek urgent medical attention if you experience any of the following:

• Sudden loss or blurring of vision in one eye, even if it is painless.
• A dark shadow or curtain moving across part of your visual field.
• A sudden shower of new floaters or flashes of light, which can signal bleeding inside the eye or a retinal tear.
• New eye pain, redness, or headache in an eye already diagnosed with a retinal vein occlusion, which may indicate dangerously high eye pressure.
• Distortion of central vision, such as straight lines suddenly appearing wavy or bent.
• Any vision change in your remaining good eye if you have already lost sight in the other eye.

If you have risk factors such as high blood pressure, diabetes, glaucoma, or a history of blood clots, regular eye examinations are a sensible precaution even when your vision feels normal, because early retinal changes can sometimes be detected before symptoms appear. Retinal conditions such as central retinal vein occlusion are evaluated and managed by ophthalmology and retina specialists, including those at Acibadem’s eye care units, working together with physicians who manage the underlying vascular risk factors.